Quantum Biopharma (QNTM) Total Debt (2024 - 2026)
Quantum Biopharma (QNTM) reported Total Debt of $485517.0 for Q1 2026, up 209.4% on a YoY basis from $156920.0 in Q1 2025, and up 2.76% sequentially from $472497.0 in Q4 2025.
Quantum Biopharma (QNTM) Total Debt (2024 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 3 years of Total Debt data on file, last reported at $485517.0 in Q1 2026.
- For the quarter ending Q1 2026, Total Debt rose 209.4% year-over-year to $485517.0; the trailing twelve-month figure through Mar 2026 stood at $485517.0 (up 209.4% YoY), and the FY2025 full-year result was $472497.0, up 210.62% from the prior year.
- Total Debt advanced to $485517.0 in Q1 2026, from $472497.0 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $485517.0 in Q1 2026 to a low of $152113.0 in Q4 2024.
- A 3-year average of $310186.2 and a median of $297035.0 in 2025 frame the typical range for Total Debt.
- Across the five-year window, Total Debt jumped 210.62% in 2025 and surged 209.4% in 2026, its largest moves.
- Tracing QNTM's Total Debt over 3 years: stood at $152113.0 in 2024, then jumped by 210.62% to $472497.0 in 2025, then advanced by 2.76% to $485517.0 in 2026.
- Business Quant data shows QNTM's Total Debt at $485517.0 in Q1 2026, $472497.0 in Q4 2025, and $429995.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Quantum Biopharma | 2.61 Bn | 2.60 Bn | - | 485,517.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 485,517.00 |
| Dec 31, 2025 | 472,497.00 |
| Sep 30, 2025 | 429,995.00 |
| Jun 30, 2025 | 164,075.00 |
| Mar 31, 2025 | 156,920.00 |
| Dec 31, 2024 | 152,113.00 |